Thoracic Oncology Program »  Research »  Clinical Trials
 
    Thoracic Oncology Programs & Labs
    Dept. of Surgery Websites

    Message from the Director

    David M. Jablons, M.D.
     Professor & Chief, Thoracic Surgery

    Program Leader, Thoracic Oncology Program

    Director, Thoracic Oncology Lab

    Make a Gift

    A gift to the Thoracic Oncology Progam helps us discover new treatments and cures for lung cancer, esophageal cancer and mesothelioma.

    How you can help >>

    Research Fellow Johannes Kratz, M.D. Leaves Lasting Mark on Lab

    Johannes Kratz, M.D., a research fellow in the  Thoracic Oncology Lab from 2008-11, played a pivotal role in the development of a prognostic assay for early-stage lung cancer patients, reported on in  The Lancet and  JAMA.

    Read more »
     
    Thoracic Oncology Program »  Research »  Clinical Trials

    Thoracic Oncology Clinical Trials

       Also show trials not enrolling patients
    Select by Type: 

    Brain Metastases

    Recruiting
    A Clinical Study Conducted in Multiple Centers Comparing Veliparib and Whole Brain Radiation Therapy (WBRT) Versus Placebo and WBRT in Subjects With Brain Metastases From Non Small Cell Lung Cancer (NSCLC)
    Study ID: UCSF-12653
    Principal Investigator:
    Matthew A. Gubens, M.D., M.S.
    Enrolling patients
    RecruitingRecruitingRecruitingRecruitingActive, not recruitingActive, not recruitingNot yet recruitingActive, not recruitingActive, not recruitingRecruitingRecruitingRecruitingActive, not recruitingRecruitingRecruitingRecruitingRecruitingActive, but closed to enrollmentRecruitingRecruitingNot yet recruitingActive, but closed to enrollmentRecruitingActive, not recruitingRecruitingRecruitingRecruitingActive, not recruitingRecruitingRecruitingRecruitingRecruitingRecruiting

    Carcinoid Tumor

    RecruitingRecruitingRecruiting
    A Study of Axitinib in Advanced Carcinoid Tumors
    Study ID: UCSF-114520
    Principal Investigator:
    Emily Bergsland, M.D.
    Enrolling patients
    RecruitingRecruitingActive, not recruitingActive, not recruitingNot yet recruitingActive, not recruitingActive, not recruitingRecruitingRecruitingRecruitingActive, not recruitingRecruitingRecruitingRecruitingRecruitingActive, but closed to enrollmentRecruitingRecruitingNot yet recruitingActive, but closed to enrollmentRecruitingActive, not recruitingRecruitingRecruitingRecruitingActive, not recruitingRecruitingRecruitingRecruitingRecruitingRecruiting

    Esophageal Cancer

    RecruitingRecruitingRecruitingRecruitingRecruitingActive, not recruitingActive, not recruitingNot yet recruitingActive, not recruitingActive, not recruitingRecruitingRecruitingRecruitingActive, not recruitingRecruitingRecruitingRecruitingRecruiting
    PET Scan Imaging in Assessing Response in Patients With Esophageal Cancer Receiving Combination Chemotherapy
    Study ID: CALGB-80803
    Principal Investigator:
    Alan P. Venook, M.D.
    Enrolling patients
    Active, but closed to enrollmentRecruitingRecruitingNot yet recruitingActive, but closed to enrollmentRecruitingActive, not recruitingRecruitingRecruitingRecruitingActive, not recruitingRecruitingRecruitingRecruitingRecruitingRecruiting

    Mesothelioma

    RecruitingRecruitingRecruitingRecruitingRecruitingActive, not recruitingActive, not recruitingNot yet recruitingActive, not recruitingActive, not recruitingRecruitingRecruitingRecruitingActive, not recruitingRecruitingRecruitingRecruiting
    Pemetrexed Disodium or Observation in Treating Patients With Malignant Pleural Mesothelioma Without Progressive Disease After First-Line Chemotherapy
    Study ID: CALGB-30901
    Principal Investigator:
    Thierry Marie Jahan, M.D.
    Enrolling patients
    RecruitingActive, but closed to enrollmentRecruitingRecruitingNot yet recruitingActive, but closed to enrollmentRecruitingActive, not recruitingRecruitingRecruitingRecruitingActive, not recruitingRecruitingRecruitingRecruitingRecruitingRecruiting

    Non-Small Cell Lung Cancer

    RecruitingRecruitingRecruitingRecruitingRecruitingActive, not recruitingActive, not recruitingNot yet recruitingActive, not recruitingActive, not recruitingRecruitingRecruitingRecruiting
    Gemcitabine Hydrochloride or Pemetrexed Disodium and Carboplatin With or Without Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Cancer
    Study ID: CALGB-30801
    Principal Investigator:
    Sunny Wang, M.D.
    Enrolling patients
    Active, not recruitingRecruitingRecruitingRecruitingRecruitingActive, but closed to enrollmentRecruitingRecruitingNot yet recruitingActive, but closed to enrollmentRecruitingActive, not recruitingRecruitingRecruiting
    Stereotactic Body Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer
    Study ID: RTOG-0813
    Principal Investigator:
    Alexander R. Gottschalk, M.D., Ph.D.
    Enrolling patients
    Recruiting
    Study Assessing Safety, Pharmacokinetics and Efficacy of CC-223 With Either Erlotinib or Oral Azacitidine in Advanced Non-Small Cell Lung Cancer
    Study ID: UCSF-12954
    Principal Investigator:
    Matthew A. Gubens, M.D., M.S.
    Enrolling patients
    Active, not recruitingRecruiting
    Study of MK-3475 in Participants With Progressive Locally Advanced or Metastatic Carcinoma, Melanoma, or Non-small Cell Lung Carcinoma (P07990/MK-3475-001 AM6)
    Study ID: UCSF-11857
    Principal Investigator:
    Adil I. Daud, M.D.
    Enrolling patients
    RecruitingRecruitingRecruitingRecruiting
    Surgery With or Without Internal Radiation Therapy Compared With Stereotactic Body Radiation Therapy in Treating Patients With High-Risk Stage I Non-Small Cell Lung Cancer
    Study ID: CTSU-RTOG1021
    Principal Investigator:
    Sue S. Yom, M.D., Ph.D.
    Enrolling patients

    Solid Tumor

    RecruitingRecruiting
    A Safety Study of MM-121 With Cetuximab and Irinotecan in Patients With Advanced Cancers
    Study ID: UCSF-11956
    Principal Investigator:
    W. Michael Korn, M.D.
    Enrolling patients
    RecruitingRecruiting
    A Study of IMC-CS4 in Subjects With Advanced Solid Tumors
    Study ID: UCSF-11993
    Principal Investigator:
    Hope Rugo, M.D.
    Enrolling patients
    Recruiting
    A Study of LY2875358 in Patients With Advanced Cancer
    Study ID: UCSF-109910
    Principal Investigator:
    Alain Algazi, M.D.
    Enrolling patients
    Active, not recruitingActive, not recruitingNot yet recruiting
    A Study of the Safety and Pharmacokinetics of AGS-22M6E in Subjects With Malignant Solid Tumors That Express Nectin-4
    Study ID: UCSF-12955
    Principal Investigator:
    Hope Rugo, M.D.
    Not yet enrolling
    Active, not recruitingActive, not recruitingRecruiting
    Dose-Escalation Study of GSK2126458
    Study ID: UCSF-09992
    Principal Investigator:
    Pamela Munster, M.D.
    Enrolling patients
    Recruiting
    Eribulin in Combination With Cyclophosphamide in Patients With Solid Tumor Malignancies
    Study ID: UCSF-11996
    Principal Investigator:
    Hope Rugo, M.D.
    Enrolling patients
    RecruitingActive, not recruitingRecruiting
    MK-2206, Paclitaxel and Trastuzumab in Treating Patients With HER2-overexpressing Solid Tumor Malignancies
    Study ID: UCSF-10998
    Principal Investigator:
    A. Jo Chien, M.D.
    Enrolling patients
    Recruiting
    Panobinostat and Epirubicin in Treating Patients With Metastatic Malignant Solid Tumors
    Study ID: UCSF-09991
    Principal Investigator:
    Pamela Munster, M.D.
    Enrolling patients
    RecruitingRecruitingActive, but closed to enrollmentRecruiting
    Phase I Tolerability, Efficacy, and Safety Study of Pazopanib in Combination With PCI-24781 in Patients With Metastatic Solid Tumors
    Study ID: UCSF-11955
    Principal Investigator:
    Pamela Munster, M.D.
    Enrolling patients
    Recruiting
    Phase I/Ib Dose-escalation of Dinaciclib With Weekly Paclitaxel for Advanced Solid Tumor Malignancies & Assessment of MYC Oncogene Overexpression
    Study ID: UCSF-12951
    Principal Investigator:
    A. Jo Chien, M.D.
    Enrolling patients
    Not yet recruiting
    Phase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid Tumors
    Study ID: NCT01576666
    Principal Investigator:
    Pamela Munster, M.D.
    Not yet enrolling
    Active, but closed to enrollmentRecruiting
    Safety and Tolerability of Different Dose Combinations of Ridaforolimus With MK-2206 or MK-0752 for Participants With Advanced Cancer (MK-8669-049 AM1)
    Study ID: UCSF-11991
    Principal Investigator:
    Pamela Munster, M.D.
    Enrolling patients
    Active, not recruitingRecruiting
    Safety Study of PLX3397 and Paclitaxel in Patients With Advanced Solid Tumors
    Study ID: UCSF-12953
    Principal Investigator:
    Hope Rugo, M.D.
    Enrolling patients
    RecruitingRecruitingActive, not recruitingRecruitingRecruiting
    Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma or Multiple Myeloma
    Study ID: UCSF-11995
    Principal Investigator:
    Pamela Munster, M.D.
    Enrolling patients
    Recruiting
    Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma or Multiple Myeloma
    Study ID: UCSF-11954
    Principal Investigator:
    Pamela Munster, M.D.
    Enrolling patients
    Recruiting
    Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma
    Study ID: UCSF-10993
    Principal Investigator:
    Pamela Munster, M.D.
    Enrolling patients
    Recruiting
    X